Galcanezumab
- Generic Name
- Galcanezumab
- Brand Names
- Emgality
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1578199-75-3
- Unique Ingredient Identifier
- 55KHL3P693
- Background
Galcanezumab is a humanized monoclonal antibody developed by Eli Lilly and Company against human calcitonin gene-related peptide (CGRP). Although several small-molecule CGRP receptor antagonists have been developed, humanized monoclonal antibodies like galcanezumab are specifically designed to selectively bind to CGRP entities with high potency. Given this t...
- Indication
Galcanezumab is indicated in adults for the preventive treatment of migraine and the treatment of episodic cluster headache.
- Associated Conditions
- Episodic Cluster Headache, Migraine
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath